Atypical MRI presentation of symmetrical thalamic and basal ganglia lesions in adult-onset MOG-IgG-associated disease: a case report. [PDF]
Wang Y, Xin Z, Meng R, Zhao Z, Zhu Z.
europepmc +1 more source
Use of Fluid Biomarkers in NMOSD and MOGAD: Clinical and Research Applications. [PDF]
Mariotto S +15 more
europepmc +1 more source
Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. [PDF]
Vilaseca A +57 more
europepmc +1 more source
Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated Disease Presenting as Acute Disseminated Encephalomyelitis Following COVID-19 mRNA Vaccination. [PDF]
He M, Bondoc C, Fekete R.
europepmc +1 more source
MOG Antibody-Associated Disease With Bilateral Deep Gray Matter Involvement in a Child: Unique MRI Findings and Therapeutic Response. [PDF]
Saymeh A +6 more
europepmc +1 more source
Amaç:Miyelinoligodendrositglikoprotein(MOG)antikoruileilişkilihastalık(MOGAD)santralsinirsisteminin(SSS)otoimmündemiyelinizanhastalığıdır.Çocuklardatümakutdemiyelinizansendromlarınyaklaşıküçtebirinioluşturmaktadır.
Arhan, Ebru +8 more
core
Eculizumab treatment in the salvage therapy of MOGAD: a case report. [PDF]
Guo Y, Liu M, Zhang Z.
europepmc +1 more source
MOGAD-Like Encephalitic Syndromes Without MOG Antibodies in Children. [PDF]
Olivé-Cirera G +22 more
europepmc +1 more source
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) was defined as a neuroimmune disorder of the central nervous system in 2007. In recent years, clinicians and researchers have been working to identify the mechanisms behind the
Abraham, Freya
core

